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Abstract 
Toll-like receptors (TLRs) are a major group of pattern recognition receptors 
expressed on the surface of immune cells that recognize molecular patterns associated 
with all classes of pathogenic microorganisms.  TLR4 recognizes the lipopolysaccharide 
component of Gram-negative bacterial cell walls and is the only TLR known to induce 
signaling through both the MyD88 and TRIF pathways.  Basigin, a ubiquitous cell adhesion 
molecule, is a member of the immunoglobulin superfamily that has the ability to influence 
cell signaling mediated by the MyD88 and TRIF pathways, the same signaling pathways 
induced by the TLR4 receptor protein.  Analysis of the Basigin protein sequence indicates 
the presence of a hydrophilic glutamate residue within the hydrophobic transmembrane 
domain, but no consensus binding sites for MyD88 or TRIF. The purpose of this study was 
to determine if Basigin uses TLR4 for signal transduction.  It is hypothesized that Basigin 
interacts with TLR4 and that the glutamate residue plays a role in the interaction.  Enzyme-
linked immunosorbent binding assays were performed using endogenous TLR4 and 
recombinant Basigin proteins.  These analyses demonstrated that binding of Basigin to 
TLR4 was significantly greater than that of the control protein and that the glutamate 
residue in the Basigin transmembrane domain does play a role in the interaction between 
Basigin and TLR4 as well as many hydrophobic residues in the Basigin transmembrane 
domain. The data suggest that Basigin interacts with TLR4 to influence signaling cascades 
using MyD88 and TRIF.  
 1 
Chapter 1 - Introduction 
Immune-mediated pathogen recognition and destruction occurs via collaboration of 
the innate and adaptive immune responses.  The immune system is collectively comprised 
of these two processes to facilitate host protection from deleterious factors within the 
environment.  The innate immune response is a rapidly generated early line of defense that 
occurs as a result of pathogen recognition and works using antimicrobial peptides and the 
complement system to eliminate pathogens (reviewed by Hendry et al., 2013).  The innate 
response is often sufficient in eliminating the identified invading pathogen, but in 
circumstances where the innate response is insufficient, the adaptive response ensues and 
functions until the pathogen is successfully eliminated (reviewed by Hendry et al., 2013).  
Unlike the immediate response of innate immunity, adaptive immunity is long lasting and 
responsible for the production of antibodies (reviewed by Hendry et al., 2013).  The innate 
immune system is initiated by the recognition of pathogenic organisms such as bacteria, 
viruses, fungi, or parasites and involves various proteins including immune cell surface 
receptors.  Immune cell surface receptors directly interact with the pathogen or products 
of the pathogen for the purpose of self- vs. non-self-discrimination, and thus these 
recognizable products are specific to pathogenic entities.  After pathogen recognition, 
immune cell receptors are known to induce signaling cascades that result in the production 
of pro-inflammatory cytokines and subsequent inflammation.  Cytokines generate 
inflammatory responses by acting as signaling proteins that can recruit additional cells to 
the site of injury or by increasing the number of white blood cells known as macrophages 
at the site of infection for the purpose of increased phagocytosis (reviewed by Hendry et 
al., 2013).  Inflammation is the process by which heat, redness, pain, swelling, and even 
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loss of function can occur at the local site of infection.  A superabundance of inflammation 
can result in septic shock (reviewed by Wiersinga et al., 2014)   
 Many key molecules are involved in the intricate processes of both innate and 
adaptive immunity.  Cell adhesion molecules are thought to play essential roles in the 
immune response in addition to facilitating cell attachment, specifically by influencing pro-
inflammatory intracellular signaling events and subsequent production of cytokines 
(reviewed by Agrawal and Yong, 2011).  Cell adhesion molecules also play large roles in 
allowing immune cells to travel to and enter tissues from the bloodstream (reviewed by 
Agrawal and Yong, 2011).  
 Cell adhesion molecules (CAMs) are transmembrane proteins involved in 
extracellular recognition and cell attachment and can be categorized according to whether 
or not they utilize calcium (Sonderegger, 1998).  Molecules that are members of the 
integrins, selectins, or cadherins are all calcium dependent, whereas members of the 
immunoglobulin superfamily are calcium independent molecules (Sonderegger, 1998; 
Figure 1.1).  Molecules of the immunoglobulin superfamily are known for their roles in 
facilitating cell adhesion in addition to activating signaling pathways within the cell 
(Pollerberg et al., 2013).  The members of the immunoglobulin superfamily can be defined 
by extracellular regions that contain immunoglobulin-like domains formed by anti-parallel 
β strands connected by loops of various lengths (Sonderegger, 1998).  Disulfide bridges 
link β-strands to form the characteristic immunoglobulin-like domains and are therefore 
the distinguishing factors for this class of calcium-independent cell adhesion molecules 
(Sonderegger, 1998).  
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Figure 1.1 Comparison of calcium dependent and calcium independent cell adhesion 
molecule domains.  Members of the immunoglobulin superfamily are calcium independent 
and contain disulfide bridges known to form the characteristic immunoglobulin loop-like 
domains (top row).  Other cell adhesion molecule families are calcium dependent and do 
not contain disulfide bridges (bottom row; Sonderegger, 1998). 
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 Basigin gene products are highly glycosylated members of the immunoglobulin 
superfamily and function as cell adhesion molecules. Basigin gene products contain 
immunoglobulin-like domains within the extracellular region, a hydrophobic single-pass 
transmembrane domain, and a short cytoplasmic tail.  The Basigin gene contains eight 
exons from which two isoforms are produced via alternative splicing (Ochrietor et al., 
2003; Figure 1.2).  Exons 1 through 7 encode the protein known as Basigin, which contains 
two immunoglobulin-like domains (Ig 1 and 2) that comprise the extracellular region.  
Exons 1 through 7, in addition to exon 1A (located between exon 1 and 2), encode the 
Basigin-2 isoform, which contains three immunoglobulin-like domains that comprise the 
extracellular region of the protein.  Basigin-2 is a retina-specific isoform, while Basigin is 
ubiquitously expressed (Figure 1.3).  Although Basigin is best known for its role in cell 
adhesion, various studies have indicated that Basigin is also involved in cancer metastasis, 
regulation of associated signaling cascades, and pro-inflammatory intracellular signaling 
cascades via interactions with the cyclophilin protein (Wei et al., 2010; Sidhu et al., 2010).     
Basigin is thought to play an essential role in proper retinal function (Ochrietor et 
al., 2001; Philp et al., 2003).  In the retina, the Basigin gene codes for two polypeptides via 
splice variation known as Basigin and Basigin-2 (Ochrietor et al., 2003). Basigin contains 
two immunoglobulin-like loop domains and is ubiquitously expressed, whereas Basigin-2 
contains three immunoglobulin-like loop domains and is a retina-specific isoform of the 
Basigin gene (Ochrietor et al., 2003). It has been demonstrated that Basigin interacts with 
Basigin-2 in the retina for the purpose of cell attachment (Ochrietor et al., 2008).  It is 
proposed that this interaction exists to facilitate proper nutrition of photoreceptor cells so 
that phototransduction, and thus, proper vision can occur (Philp et al., 2003).   Both 
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Figure 1.2 Coding regions of the Basigin gene.  The Basigin gene contains eight exons.  
Exons 1 through 7 encode the Basigin protein consisting of two extracellular 
immunoglobulin domains.  Exons 1 through 7 in addition to exon 1A encode the Basigin-2 
protein consisting of the two identical immunoglobulin domains found in Basigin in 
addition to a third immunoglobulin domain that is specific to the Basigin-2 protein 
(adapted from Ochrietor et al., 2003).   
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Figure 1.3  Western blot showing the expression of Basigin gene products in mouse tissue.  
An antibody that recognized both isoforms of Basigin indicates that the Basigin protein is 
ubiquitously expressed (top panel).  Basigin is approximately 45 kDa in molecular weight 
while Basigin-2 is approximately 55 kDa in molecular weight.  An antibody specific to the 
Basigin-2 isoform shows that Basigin-2 is a retina-specific isoform (bottom panel).  R = 
retina, B = brain, Lu = lung, Li = liver, K = kidney, H = heart, S = spleen, U = uterus, T = testis, 
SM = skeletal muscle (Ochrietor et al., 2003). 
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Basigin and Basigin-2 interact with monocarboxylate transporter 1 (MCT-1) via 
hydrophobic interactions of the membrane-spanning domains (Finch et al., 2009).  
Members of the MCT family transport lactate and other monocarboxylates across the 
plasma membrane (Halestrap and Price, 1999).  The expression pattern of Basigin and 
Basigin-2 in the retina differ in that Basigin is expressed by Müller glial cells and Basigin-2 
is expressed specifically by photoreceptor cells (Ochrietor et al., 2003).  It is thought that 
Basigin interacts with Basigin-2 to tether these two cell types together so that lactate is 
able to move from Müller glial cells and into the photoreceptor cells (Philp et al., 2003).  
Lactate can be utilized by photoreceptor cells to fuel oxidative phosphorylation and 
generate energy for the process of phototransduction (Gladden, 2004).  
 Behavioral studies based on visual cues showed sensory malfunctions associated 
with Basigin-null animals, which are thought to exist due to the absence of Basigin-
mediated cell adhesion in the brain (Naruhashi et al., 1997).  Basigin-null animals are also 
less sensitive to changes in light when compared to wild type animals in that the null 
animals did not show any electroretinogram (ERG) responses (Hori et al., 2000; Ochrietor 
et al., 2002).  Studies have shown that animals in which the gene for Basigin is deleted lack 
proper maturation of the retina and exhibit retinal degeneration (Ochrietor et al., 2001).  
 In addition to cell attachment, members of the immunoglobulin superfamily are 
known to influence cell signaling.  In humans, Basigin has been implicated as an essential 
regulatory component in signaling pathways associated with cancer development and 
metastasis (Sidhu et al., 2010).  Lung epithelial tumor cells in which Basigin was increased 
showed increased amounts of signaling through the Wnt/beta-catenin signaling pathway, 
while decreases in Basigin resulted in decreased intracellular signaling (Sidhu et al., 2010).  
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Basigin mRNA and protein were shown to be the most frequently up-regulated products in 
metastatic cancer cells isolated from bone marrow, a correlation indicative of tumor 
progression (reviewed by Nabeshima et al., 2006).  These findings demonstrate that 
Basigin may behave as a regulatory component in the intracellular signaling and cell 
attachment involved in tumor metastasis.   
 There is strong evidence for the involvement of Basigin in immune response 
signaling and subsequent inflammation.  In humans, Basigin was shown to induce pro-
inflammatory intracellular signaling cascades in response to cyclophillin, a protein that is 
characterized as a cytosolic peptidylprolyl isomerase that functions to catalyze the 
isomerization of peptide bonds from trans to cis at proline amino acid residues (Wei et al., 
2010).  Elevated cyclophillin levels are associated with atherosclerotic plaques, in which 
monocytes and other cells secrete cyclophillin in response to reactive oxygen species.  
Cyclophillin acts as a chemoattractant to recruit other immune cells and causes induction 
of signaling inside the cell (Wei et al., 2010).  Reactive oxygen species in immune cells are 
commonly associated with pathogen internalization and precedes the inflammatory 
response (Wei et al., 2010). Cyclophilin was shown to induce the MAP kinase pathway 
through the Basigin protein, resulting in the activation of the transcription factor NF-
kappaB and subsequent release of pro-inflammatory cytokines. (Wei et al., 2010).  The 
study by Wei et al. demonstrated that the effects of cyclophillin were terminated when 
Basigin was down-regulated, thus indicating that Basigin is required for mediating the 
effects of cyclophillin.  
 Pattern recognition receptors (PRRs) are proteins expressed on the plasma 
membrane of macrophages and other immune cell types that are extensively involved in 
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pro-inflammatory signaling cascades associated with the innate immune response 
(reviewed by Kawasaki et al., 2014). Some PRRs can be internalized within the cell for the 
purpose of recognizing intracellular pathogens (reviewed by Kawasaki et al., 2014). PRRs 
function to recognize common patterns that are characteristic of groups of pathogens 
known as pathogen associated molecular patterns (Owen et al., 2013).  These receptors 
elicit pro-inflammatory signaling cascades that ultimately work to generate and secrete 
chemical signals known as cytokines.  Cytokines label pathogens appropriately for 
immune-mediated destruction, recruit immune cells to the site of infection, increase 
vascular permeability, and allow immune cells to communicate effectively, all of which 
elicits inflammation as part of the innate immune response (Owen et al., 2013).  Pattern 
recognition receptors often function as the first line of defense against foreign invaders 
and include four classes of receptors:  Toll-like receptors (TLRs), C-type lectin receptors 
(CLRs), Retinoic acid-inducible gene I-like receptors (RLRs), and Nod-like receptors (NLRs) 
(Owens et al., 2013). 
 Toll-like receptors are perhaps the most well understood and extensively studied 
PRRs.  Collectively, the toll-like receptor family recognizes all of the major classes of 
pathogens including those from bacteria, viruses, fungi, and parasites (reviewed by 
Kawasaki et al., 2014; Figure 1.4).  TLRs have single membrane-spanning domains and 
extensive extracellular domains consisting of many leucine-rich repeats that make up the 
ligand-binding region of the receptor.  The cytoplasmic domains interact with adaptor 
proteins via toll-interferon-1 receptor (TIR) domains to induce signaling (Lu et al., 2008).  
When members of the TLR family bind to their specific ligands, the receptors dimerize 
either with themselves or, in some cases, with other members of the TLR family (Lu et al.,  
 10 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4 Toll-like receptor family members and their ligands.  All toll-like receptors 
contain leucine rich repeats that comprise the extracellular domain and a TIR signaling 
domain comprising the cytoplasmic tail (Armant and Fenton, 2002).  
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2008).  TLR4 specifically recognizes lipopolysaccharide, a component of Gram-negative 
bacterial cell walls (Lu et al., 2008).  TLR4 is the only family member that can be 
internalized from the plasma membrane or remain at the plasma membrane after binding 
to lipopolysaccharide, and thus has the ability to induce two different intracellular 
signaling cascades, one from each of the two locations (Owen et al., 2013).  If TLR4 binds to 
LPS at the plasma membrane, the MyD88 (Myeloid differentiation factor 88) signaling 
pathway is used (Owen et al., 2013).  If TLR4 is internalized in an endosome, the TRIF (TIR-
domain-containing adaptor-inducing IFN-beta factor) signaling pathway is used (Owen et 
al., 2013).  The transcription factor NF-kappaB is activated via both the MyD88 and TRIF 
signaling pathways and initiates the transcription of pro-inflammatory cytokines.  These 
cytokine proteins function as part of the innate immune system.  
 TLR proteins form protein complexes via their extracellular domains that function 
in the recognition of and binding to their specific ligands.  TLR4 forms a complex with 
CD14 and MD2 via its extracellular domain (Parham, 2015). CD14 transfers 
lipopolysaccharide to the TLR4 extracellular domain (Parham, 2015).  This transfer is then 
recognized by MD-2, which allows for the protein to dimerize and subsequently induce 
signaling (Parham, 2015). TLRs have unique associated signaling pathways determined by 
the TLR region (TIR domain) and the associated adaptor protein involved in the TLR 
cytoplasmic domain complex (Owen et al., 2013).  When members of the TLR family 
dimerize after binding to their ligand, TIR domains change conformation and bind to the 
specific adaptor protein that will be associated with that particular TLR cytoplasmic 
domain, which activates the appropriate signaling cascades specific to the associated 
adaptor protein (Figure 1.5). Two of these key adaptors are MyD88 and TRIF (reviewed by  
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Figure 1.5 TLR4 signaling.  Intracellular signaling through the MyD88 pathway in response 
to activation of TLR4 by LPS (Parham, 2015). 
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Kawasaki et al., 2014).  Most TLRs (especially those involved in bacterial recognition) bind 
to the adaptor MyD88 to initiate MyD88-dependent signaling pathways (reviewed by 
Kawasaki et al., 2014).  TLR4 has the unique ability to bind to both MyD88 and TRIF 
adaptor proteins and initiate both MyD88 and TRIF-dependent signaling pathways 
(reviewed by Kawasaki et al., 2014).  TLR4 binds MyD88 when it is embedded in the 
plasma membrane or binds TRIF when it is located within endosomes following 
internalization (Zanoni et al., 2011).  Two other adaptors are necessary for proper 
functioning of the TLRs and include TIRAP (TIR-domain containing adaptor protein) and 
TRAM (TRIF-related adaptor molecule; Parham, 2015).  Both are adaptor proteins that 
recruit either MyD88 (TIRAP) or TRIF (TRAM), depending on where the TLR protein is 
located.  Thus, TIRAP and TRAM dictate which signaling pathway is utilized in addition to 
the receptor location.  
The TLR4 protein is expressed on the surface of immune cells of both myeloid and 
lymphoid subsets, including monocytes, macrophages, and dendritic cells (both mature 
and immature) in mice (Vaure and Liu, 2014).  TLR4 is expressed exclusively by microglia 
in mouse brain and is also expressed in mouse heart, kidney, liver, lung, pancreas, smooth 
muscle, and spleen (Vaure and Liu, 2014).  TLR4 had greater expression in mouse heart 
and lung compared to other mouse organs (Vaure and Liu, 2014).  In rats, TLR4 is detected 
in individuals with normal blood pressure but is upregulated in individuals with 
hypertension, suggesting that it may play a role in cardiovascular disorders (Eissler et al., 
2011; Figure 1.6).  This upregulation was reversed when the hypertension was reduced 
with a dose of Ramipril (Eissler et al., 2011). 
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Figure 1.6 TLR4 is expressed in rodent cardiomyocytes and is upregulated in response to 
hypertension.  Immunohistochemistry showing expression of TLR4 in rat cardiomyocytes.  
A. TLR4 was detected in control rats that were normotensive (WKY).  B. Rats that 
experienced hypertension (SHR) showed an upregulation of TLR4 in cardiomyocytes 
compared to normotensive rats.  C.  Ramipril was given as a treatment to reduce 
hypertension in SHR rats simultaneously reversing TLR4 upregulation (Eissler et al., 
2011).   
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In the retina, TLRs were characterized as fully functional receptors with the 
capability to induce an innate immune response following stimulation with pathogenic 
ligands in a 661W photoreceptor cell line (Singh and Kumar, 2015).   In that study, TLRs 
were localized to both Müller glial cells and photoreceptor cells (Singh and Kumar, 2015). 
In 2014, Jeong et al. reported that Basigin influenced the signaling pathways 
mediated by accessory proteins MyD88 and TRIF.  Basigin was linked to NF-kappaB 
activation via both MyD88 and TRIF pathways, in that signaling occurred in the presence of 
Basigin, but when Basigin was knocked down, signaling was decreased by about 85 
percent (Jeong et al., 2014).  The same study indicated that when an antibody specific for 
Basigin was applied, signaling was also decreased by about 40 percent (Jeong et al., 2014).  
Although the MyD88 signaling pathway is commonly induced by most of the TLRs in  
response to ligand binding, the only member of the TLR family that has the ability to 
induce signaling through both MyD88 and TRIF signaling pathways is TLR4.   
Despite the influential nature of the Basigin protein in the pro-inflammatory 
signaling cascades associated with MyD88 and TRIF pathways, Basigin has not been shown 
to directly interact with the TLR4 protein. Both Basigin and TLR4 are expressed by many 
of the same tissues in mice (Ochrietor et al., 2003, Eissler et al., 2011).  The TLR4 protein 
forms extensive complexes with other proteins via both the extracellular and cytoplasmic 
domains to induce signaling in response to the recognition of LPS.   
The purpose of this study is to determine if an interaction exists between Basigin 
and TLR4 and to determine which amino acid residues in the Basigin transmembrane 
domain may be important for stabilizing the interaction.  It is hypothesized that Basigin 
will interact with TLR4 and that the charged glutamate residue within the Basigin 
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transmembrane domain will be important for stabilizing the interaction. Investigating 
these aspects of immune-mediated pro-inflammatory signaling events will collectively 
increase the understanding of the interactions that occur at the cellular level during the 
process of inflammation.  Understanding the role that Basigin plays in TLR4 signaling 
pathways and how it is connected to the development of inflammation through TLR4 could 
be crucial for a better understanding of how these processes occur. 
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Chapter 2 - Methods 
Expression plasmids 
 Expression plasmids containing the cDNA for the entire Basigin transmembrane 
domain (pET102-BasTM-all), as well as the truncated portions of the domain (pET102-
BasTM-1-6, pET102-BasTM-7-12, pET102-BasTM-13-18, and pET102-BasTM-19-24) were 
generated previously (Finch et al., 2009).  In addition, the plasmid containing the cDNA for 
the entire Basigin transmembrane domain with the coding sequence for glutamate 
mutated to glycine (pET102-BasTM-all-E13G) and the plasmids in which the coding 
sequences for the individual amino acids are each mutated to glycine (pET102-BasTM-1-6-
M1G, pET102-BasTM-1-6-A2G, pET102-BasTM1-6-A3G, pET102-BasTM1-6-L4G; pET102-
BasTM1-6-W5G, and pET102-BasTM-1-6-P5G) were previously generated (Finch et al., 
2009).  For these plasmids, the cDNA was cloned into the bacterial expression plasmid 
pET102 (Invitrogen Corporation, Carlsbad, CA).  This plasmid allows for recombinant 
protein expression using BL21 cells (Invitrogen Corporation) in which the protein product 
contains six histidines at the carboxy-terminus.  The plasmid codes for 157 amino acids, 
which allows the six to 24 amino acids of the hydrophobic transmembrane domain to be 
expressed as soluble proteins (Finch et al., 2009).  
 
Site Directed Mutagenesis 
For mutation of the coding sequences of individual amino acids within the pET102-
BasTM 7-12 and pET102 BasTM 13-18 plasmids, 1 μl dNTP mix, 1 μl pET102 BasTM 7-12 
plasmid DNA or pET102 BasTM 13-18 plasmid DNA (Finch et al., 2009), 5 μl 10X Buffer, 1 
μl forward primer (Table 2.1), 1 μl reverse primer (Table 2.1), and 3 μL Quick Solution  
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Table 2.1  Basigin transmembrane domain mutagenesis primers 
 
 
Primer Sequence 
BasTM 7-12 F7G F 5’-GGGAATTGATCCCTTCACCGGCCTAGGCATCGTGGCTAAG 
BasTM 7-12 F7G RV 5’-CTTAGCCACGATGCCTAGGCCGGTGAAGGGATCAATTCCC 
BasTM 7-12 L8G F 5’-GAATTGATCCCTTCACCTTCGGGGGCATCGTGGCTAAGGGCGAG 
BasTM 7-12 L8G RV 5’-CTCGCCCTTAGCCACGATGCCCCCGAAGGTGAAGGGATCAATTC 
BasTM 7-12 I10G F 5’-CCCTTCACCTTCCTAGGCGGGGTGGCTAAGGGCGAGCTC 
BasTM 7-12 I10G RV 5’-GAGCTCGCCCTTAGCCACCCCGCCTAGGAAGGTGAAGGG 
BasTM 7-12 V11G F 5’-CCTTCCTAGGCATCGGCGCTAAGGGCGAGCTC 
BasTM 7-12 V11G RV 5’-GAGCTCGCCCTTAGGCCCGATGCCTAGGAAGG 
BasTM 7-12 A12G F 5’-CTTCCTAGGCATCGTGGGGAAGGGCGAGCTCAAGC 
BasTM 7-12 A12G RV 5’-GCTTGAGCTCGCCCTTCCCCCACGATGCCTAGGAAG 
BasTM 13-18 E13G F 5’-GGAATTGATCCCTTCACCGGGGTCCTGGTGTTGGTTAAG 
BasTM 13-18 E13G RV 5’-CTTAACCAACACCAGGACCCCGGTGAAGGGATCAATTCC 
BasTM 13-18 V14G F 5’-GAATTGATCCCTTCACCGAGGGCCTGGTGTTGGTTAAGGGCGAG 
BasTM 13-18 V14G RV 5’-CTCGCCCTTAACCAACACCAGGCCCTCGGTGAAGGGATCAATTC 
BasTM 13-18 L15G F 5’-CCTTCACCGAGGTCGGGGTGTTGGTTAAGG 
BasTM 13-18 L15G RV 5’-CCTTAACCAACACCCCGACCTCGGTGAAGG 
BasTM 13-18 V16G F 5’-CTTCACCGAGGTCCTGGGGTTGGTTAAGGGCGAG 
BasTM 13-18 V16G RV 5’-CTCGCCCTTAACCAACCCCAGGACCTCGGTGAAG 
BasTM 13-18 L17G F 5’-CACCGAGGTCCTGGTGGGGGTTAAGGGCGAGCTC 
BasTM 13-18 L17G RV 5’-GAGCTCGCCCTTAACCCCCACCAGGACCTCGGTG 
BasTM 13-18 V18G F 5’-CGAGGTCCTGGTGTTGGGGAAGGGCGAGCTCAAGC 
BasTM 13-18 V18G RV 5’-GCTTGAGCTCGCCCTTCCCCAACACCAGGACCTCG 
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(QuickChange® II XL Site Directed Mutagenesis Kit, Stratagene, La Jolla, CA) were 
combined in a final volume of 50 μl.  One microliter of PfuUltra™ high-fidelity DNA 
Polymerase (Stratagene) was added and the solution was subjected to thermal cycling in 
which the following cycling parameters were utilized:  95°C for 1 minute followed by 18 
cycles of 95°C for 50 seconds, 60°C for 50 seconds, 68°C for 5 minutes and finally 1 cycle of 
68°C for 7 minutes.  A restriction digest was performed in which 1 μl of the restriction 
enzyme Dpn I was added to each reaction sample followed by incubation at 37°C for 1 
hour. 
The resulting plasmids were then transformed into bacterial cells.  Two microliters 
of the appropriate plasmid DNA were added into 50 μl XL10-Gold® Ultracompetent cells 
(Strategene).  The solution was incubated on ice for 20 minutes followed by incubation at 
42°C for 30 seconds.  Two hundred fifty microliters SOC broth was added and the cells 
were incubated at 37°C for 1 hour with shaking.  The contents of the solution were 
transferred to an LB agar plate containing carbenicillin (50 μg/mL) and incubated at 37°C 
overnight.  
Selected colonies of XL10-Gold® Ultracompetent cells (Strategene) were isolated 
from the LB agar plate and added to 3 mL LB broth.  The solution was incubated overnight 
at 37°C with shaking.   
Plasmids were purified using the QIAprep miniprep protocol (QIAGEN Corporation, 
Valencia, CA).  One thousand five hundred microliters of culture (from each culture 
incubated overnight) was centrifuged at 13,000 rpm for 1 minute.  Two hundred fifty 
microliters buffer P1 (QIAprep® Miniprep, Qiagen) were added to resuspend the pelleted  
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bacterial cells, followed by the addition of 250μL buffer P2.  The tubes were inverted 6 
times, followed by the addition of 350μL buffer N3.  The tubes were inverted 6 times, 
followed by centrifugation at 13,000 rpm for 10 minutes.  Supernatants were applied to 
spin columns, followed by centrifugation at 13,000 rpm for 1 minute.  The flow-through 
was discarded and 500μL buffer PB was applied to the spin columns.  The spin columns 
were centrifuged at 13,000 rpm for 1 minute and the flow-through was discarded.  Seven 
hundred fifty microliters buffer PE were applied to the spin columns, followed by 
centrifugation at 13,000 rpm for 1 minute.  The flow-through was discarded and the spin 
columns were centrifuged once again in the absence of buffer at 13,000 rpm for 1 minute.  
Fifty microliters buffer EB were applied to the spin columns, followed by incubation at 
room temperature for 1 minute and subsequent centrifugation at 13,000 rpm for 1 minute.  
The flow-through containing eluted plasmid DNA was saved. 
Sequences were verified by the Operon-Eurofin Corporation (Louisville, KY) and 
subsequently analyzed using the ExPASy Bioinformatics Research Portal maintained by the 
Swiss Institute of Bioinformatics (web.expasy.org/translate). 
 
Recombinant Protein Expression and Purification 
Two microliters of appropriate plasmid were added into 50μL of BL21 E.coli cells 
(Invitrogen Corporation, Carlsbad, CA).  The solution was incubated on ice for 20 minutes 
followed by incubation at 42°C for 30 seconds.  Two hundred fifty microliters of SOC broth 
was added and the cells were incubated at 37°C for 1 hour with shaking.  The cells were 
transferred to 10 mL LB broth containing carbenicillin (50 μg/mL) and incubated at 37°C 
overnight with shaking. The entire overnight culture containing plasmid was added to 250 
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mL LB broth containing carbenicillin (50 μg/mL) and incubated for 3 hours at 37°C with 
shaking.  Two hundred fifty microliters of 1M IPTG was added and the culture was 
incubated overnight at 37°C with shaking.   
For purification, two hundred fifty milliliters of overnight culture were centrifuged 
at 3,000 rpm for 15 minutes.  Pelleted bacterial cells were re-suspended in 10 mL Talon 
Xtractor buffer (Clontech, Mountain View, CA) in addition to lysozyme (100 microliters of 
10 mg/mL) and DNase I (20 microliters) and the solution was incubated for 10 minutes at 
room temperature.  The solution was centrifuged for 20 minutes at 10,000 rpm to form a 
protein lysate.  The protein lysate was then applied to Talon metal affinity resin (Clontech) 
and purified via affinity chromatography. Protein was collected in 0.5 mL fractions and the 
content was analyzed at 280 nm.   
Protein concentration was determined using the Bradford Coomassie protein assay 
(Pierce Biotechnology, Rockford, IL, USA).  A standard curve was generated by using serial 
dilutions of bovine serum albumin (BSA) from 0.2 mg/mL to 2.0 mg/mL.  Five microliters 
of each BSA dilution was transferred to the wells of a 96 well plate in addition to 5 
microliters of recombinant protein fractions.   Absorbance at 595 nm was measured using 
a Bio-Tek plate reader (Biotek Instruments, Winooski, VT) and the average absorbance 
was obtained for each duplicate BSA dilution.  The averages were used to generate a graph 
in which the y-axis was labeled absorbance at 595 nm and the x-axis was labeled protein 
concentration in mg/mL.  An equation was obtained from the logarithmic regression of the 
average BSA dilution absorbance values and the unknown recombinant protein 
concentrations were determined from the equation. 
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Mouse Tissue Protein Lysates 
 Mice were sacrificed according to accepted protocols and tissue (retina, brain, or 
heart) was removed and immediately placed into 2 mL PBS.  The tissue was homogenized 
and the protein concentration was determined via the Bradford Coomassie protein assay 
previously described. 
 
Enzyme-Linked Immunosorbent Assay (ELISA) 
 One hundred microliters of anti-TLR4 capture antibody (Pierce/Thermo Scientific; 
0.05 μl antibody/100 μl PBS) was added to wells of a 96 well plate.  Several wells received 
100 microliters of PBS and no antibody.  The plate was incubated at 4°C overnight.  
Unbound capture antibody was removed followed by three washes with approximately 
200 μl PBS-Tween (PBS-T). One hundred microliters of bovine serum albumin (BSA; 
Pierce/ThermoScientific, Rockford, IL; diluted 1:10 in PBS) was added to wells of the plate.   
The plate was incubated at 37°C for 30 minutes.  The BSA was removed from the wells and 
they were washed three times with approximately 200 μl PBS-T.  One hundred microliters 
of endogenous proteins from mouse heart (diluted to 100 μg/mL in PBS) were added to 
wells of the plate.  The plate was incubated at 37°C for 30 minutes.  Unbound mouse heart 
proteins were removed and the wells were washed three times with approximately 200 μl 
PBS-T.  One hundred microliters of the appropriate recombinant protein were added to 
wells of the plate.  The plate was incubated at 37°C for 30 minutes.  Unbound recombinant 
proteins were removed and the wells were washed three times with approximately 200 μl 
PBS-T.  One hundred microliters of anti-6x-His primary antibody (diluted 1:1000 in PBS) 
was added to wells of the plate.  The plate was incubated at 37°C for 30 minutes.  Unbound 
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primary antibody was removed and the wells were washed three times with 
approximately 200 μl PBS-T.  One hundred microliters of alkaline phosphatase-conjugated 
goat-anti-mouse secondary antibody (AP-GAM; Pierce/ThermoScientific; diluted 1:1000 in 
PBS) was added to wells of the plate.  The plate was incubated at 37°C for 30 minutes.  
Unbound secondary antibody was removed and the wells were washed three times with 
approximately 200 μl PBS-T.  One hundred microliters of AP substrate (PNPP; Thermo 
Fisher Scientific, Rockford, IL) was added to wells of the plate.  The reactions were stopped 
by the addition of 50 μl 2N NaOH to all wells.  The absorbance in each well was measured 
at 405 nm on a Bio-Tek plate reader (Biotek Instruments, Winooski, VT) 
 To detect the presence of TLR4 and Basigin in mouse heart, one hundred 
microliters of endogenous proteins from mouse heart (diluted to 100 μg/mL in PBS) were 
added to wells of the plate.  The plate was incubated at 4°C overnight.  Unbound mouse 
heart proteins were removed. One hundred microliters of either anti-TLR4 antibody 
(Pierce/Thermo Scientific) or anti-Basigin antibody (Ochrietor et al., 2003; 0.05 μl 
antibody/100 μl PBS) were added.  The plate was incubated at 37°C for 30 minutes.  
Unbound antibody was removed and the wells were washed three times with 
approximately 200 μl PBS-T. One hundred microliters of the appropriate alkaline 
phosphatase conjugated secondary antibody (AP-GAM or AP-GAR; Pierce/Thermo 
Scientific; diluted 1:1000 in PBS) was applied to the wells, followed by an incubation at 
37°C for 30 minutes.  Unbound secondary antibody was removed and the wells were 
washed three times with approximately 200 μl PBS-T.  One hundred microliters of AP 
substrate (PNPP; Thermo Fisher Scientific) was added to wells of the plate.  The reactions 
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were stopped by the addition of 50 μl 2N NaOH to all wells.  Absorbance in each well was 
measured at 405 nm using a Bio-Tek plate reader. 
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Chapter 3 - Results 
 The aim of the present study was to investigate the relationship between the 
Basigin transmembrane domain and TLR4.  To achieve this aim, binding assays were 
employed to determine if the transmembrane domain of Basigin physically interacts with 
TLR4.  Expression plasmids containing the cDNA for the entire transmembrane domain of 
Basigin gene products, or truncated portions of the domain, cloned in frame of a six 
histidine carboxy-terminal epitope tag were previously generated (Finch et al., 2009) and 
used in the present study.  Recombinant protein expression was achieved by 
transformation of BL21 cells (Invitrogen Corporation), followed by the induction of protein 
synthesis and protein purification via affinity chromatography.  Although the 
transmembrane domain sequence for Basigin is highly hydrophobic, a soluble recombinant 
protein is generated, because the vector codes for 157 amino acids that mask the 
hydrophobic nature of that sequence (Finch et al., 2009). 
To effectively utilize the recombinant Basigin transmembrane domain proteins in 
ELISA binding assays, it was necessary to find a suitable tissue to serve as a source of 
endogenous TLR4 protein.  Reports indicate that TLR4 is expressed by microglia of the 
brain, in heart, lung, liver, pancreas, smooth muscle, spleen, and immune cells such as 
monocytes, macrophages, and dendritic cells, with highest expression in mouse heart and 
lung (Vaure and Liu, 2014). Additionally, TLR4 has previously been reported to be 
expressed in retinal cell types such as photoreceptors and Müller glial cells (Singh and 
Kumar, 2015; Kumar and Shamsuddin, 2012).  Therefore, mouse retinas were isolated, 
homogenized and subjected to an ELISA to detect the presence of endogenous TLR4.  The 
results of that initial ELISA analysis indicated that endogenous TLR4 is not detectable in 
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mouse retina.  No significant difference in TLR4 expression was observed between the 
retina lysates and bovine serum albumin (BSA), the negative control (p-value = 0.338; 
Figure 3.1A).  Similarly, data from ELISA analyses conducted using mouse brain also 
demonstrate that TLR4 is not detectable in that tissue (Figure 3.1B).  An ELISA analysis 
was next performed using mouse heart.  TLR4 expression was detected in mouse heart at a 
level significantly greater than that of the BSA negative control (p value = 0.006; Figure 
3.1C).  The subsequent analyses to investigate the Basigin-TLR4 interaction used mouse 
heart as a source for TLR4. 
In addition, it was necessary to demonstrate that Basigin is also expressed within 
mouse heart samples.  Therefore, an ELISA was performed to assay for the expression of 
endogenous Basigin in mouse heart.  It was determined that Basigin is indeed expressed in 
mouse heart, as the levels were significantly greater than those of the BSA negative control 
(p value = 1.205 x 10-5; Figure 3.2). 
Once an appropriate source of TLR4 protein was determined, ELISA binding assays 
were performed to assess the ability of the Basigin transmembrane domain to bind TLR4.  
The recombinant Basigin protein consisting of the entire transmembrane domain was first 
used in an ELISA with endogenous mouse heart TLR4.  The results indicate that the Basigin 
transmembrane domain does interact with TLR4 at a level that is significantly greater (p-
value = 9.17 x 10-5) than that of the control recombinant protein, which consists of vector-
specific amino acids (Figure 3.3). To determine whether the glutamate residue within the 
Basigin transmembrane domain is used in the interaction with TLR4, a recombinant 
Basigin transmembrane domain protein in which the transmembrane glutamate (E) 
residue was mutated to glycine (G) via site-directed mutagenesis was also used in an  
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Figure 3.1. TLR4 is present in mouse heart and was not detected in retina or brain.  Wells 
were coated with either retina lysates (A), brain lysate (B), or heart lysate (C) and bovine 
serum albumin (BSA) at 100 g/mL.  An antibody specific for the TLR4 protein (Pierce/ 
Thermo Scientific) was applied directly to the immobilized proteins and an alkaline 
phosphatase-conjugated goat anti-rabbit (AP-GAR) antibody was subsequently applied 
(Pierce/Thermo Scientific).  Binding was measured using an alkaline phosphatase 
detection system and spectrophotometric analysis at 405 nm.  Error bars represent 
standard deviations of the mean.  A Student’s T test was performed to compare detection 
of TLR4 in retina to the negative control (BSA).  * indicates a p-value of less than 0.05. 
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Figure 3.2.  Basigin is present in mouse heart.  Wells were coated with mouse heart 
proteins or bovine serum albumin (BSA) at 100 g/mL.  An antibody specific for the 
Basigin protein (Ochrietor et al., 2003) was applied directly to the proteins and an alkaline 
phosphatase-conjugated goat anti-mouse (AP-GAM) antibody (Pierce/Thermo Scientific) 
was subsequently applied.  Binding was measured using an alkaline phosphatase detection 
system and subsequent spectrophotometric analysis at 405 nm.  Error bars represent 
standard deviations of the mean.  A Student’s T test was performed to compare detection of 
Basigin in mouse heart to the negative control (BSA).  * indicates a p-value of less than 0.05. 
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ELISA.  The assay specifically tested whether the absence of the glutamate would result in 
decreased binding between Basigin and TLR4.  The results indicate that the glutamate 
residue alone does not appear to be essential for the interaction with TLR4 because 
binding of the mutated transmembrane domain to TLR4 was not significantly lower than 
that of the non-mutated transmembrane domain (p value comparing binding of the normal 
and mutated Basigin proteins = 0.106; Figure 3.3). The p values comparing binding of 
either normal Basigin or mutated Basigin to the control protein were less than 0.05 in both 
cases (Figure 3.3).  
 The affinity of each recombinant protein for TLR4 was also assessed via ELISA 
analyses.  It was determined that the affinity of the transmembrane domain of Basigin for 
TLR4 is moderate at 0.742 M and is similar to affinities for antibody-antigen interactions 
in the human immune system (Parham, 2015; Figure 3.4).  The transmembrane domain of 
Basigin with the glutamate mutation to glycine had a similar affinity (p value = 0.103) at 
0.930 M (Figure 3.5).    
To better understand what segments of the Basigin transmembrane domain were 
important for the interaction between Basigin and TLR4, recombinant Basigin proteins 
consisting of various segments of the transmembrane were generated (Finch et al., 2009) 
and used in ELISA analyses.  Figure 3.6 indicates that amino acid residues 7-12 (p value = 
0.00013), 13-18 (p value = 0.0201), and 19-24 (p value = 3.55 x 10-5) are the most essential 
for establishing the interaction with TLR4 (Figure 3.6).  The binding affinity of each of the 
Basigin recombinant proteins for TLR4 is as follows: BasTM 1-6 6XHis binding affinity = 
0.097 M (Figure 3.7 A); BasTM 7-18 6XHis binding affinity = 0.144 M (Figure 3.7 B); 
BasTM 19-24 6XHis binding affinity = 0.236 M (Figure 3.7 C); BasTM 7-12 6XHis binding  
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Figure 3.3. The Basigin transmembrane domain binds to TLR4.  The TLR4 protein was 
captured from mouse heart lysates using an antibody specific for TLR4 (Pierce/Thermo 
Scientific). The appropriate recombinant Basigin proteins were applied (BasTM or BasTM 
E13G) and a primary antibody specific for the six histidine tag (BD Biosciences) present on 
the recombinant proteins was applied.  An alkaline phosphatase-conjugated goat anti-
mouse (AP-GAM) antibody (Pierce/Thermo Scientific) was added and binding was 
measured using an alkaline phosphatase detection system and spectrophotometric analysis 
at 405 nm.  The control consisted of 157 amino acid residues encoded by the pET102 
plasmid.  Error bars represent standard deviations of the mean.  A Student’s T test was 
performed to compare binding of each recombinant Basigin protein to TLR4 with that of 
the control recombinant protein.  * indicates a p-value of less than 0.05. 
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Figure 3.4.  A binding affinity assay for Basigin transmembrane domain binding to TLR4.  
Endogenous TLR4 was captured and incubated with recombinant Basigin transmembrane 
domain (BasTM) at 0.5, 1.0, 1.5, 2.5, and 5.0 M. Binding between endogenous TLR4 and 
the recombinant Basigin protein was measured using an alkaline phosphatase detection 
system and spectrophotometric assay at 405 nm. Percent binding was calculated for each 
concentration and the binding affinity of the recombinant Basigin protein for TLR4 was 
determined from the slope equation.  All runs were performed in triplicate.  Error bars 
represent standard deviations of the mean. 
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Figure 3.5.  A binding affinity assay for BasTM E13G binding to TLR4.  Endogenous TLR4 
was captured and incubated with recombinant Basigin transmembrane domain in which 
the glutamate residue was mutated (BasTM E13G) at 0.5, 1.0, 1.5, 2.5, and 5.0 M.  Binding 
between endogenous TLR4 and the recombinant Basigin protein was measured using an 
alkaline phosphatase detection system and spectrophotometric assay at 405 nm. Percent 
binding was calculated for each concentration and the binding affinity of the mutated 
recombinant Basigin protein for TLR4 was determined using the slope equation.  All runs 
were performed in triplicate.  A Student’s T-Test was used to compare the mutated 
transmembrane binding affinity to that of the normal Basigin transmembrane domain.  A 
p-value of less than 0.05 is considered statistically significant.  Error bars represent 
standard deviations of the mean. 
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Figure 3.6.  Basigin transmembrane segments 7-12, 13-18, and 19-24 bind to TLR4. 
Endogenous TLR4 was captured using an antibody specific to TLR4 (Pierce/Thermo 
Scientific) and was incubated with the appropriate recombinant Basigin protein (BasTM 1-
6 6XHis, BasTM 7-12 6XHis, BasTM 13-18 6XHis, and BasTM 19-24 6XHis) followed by the 
application of a primary antibody specific for the six histidine tag (BD Biosciences).  An 
alkaline phosphatase-conjugated goat anti-mouse (AP-GAM) antibody (Pierce/Thermo 
Scientific) was applied. Binding was measured using an alkaline phosphatase detection 
system and spectrophotometric analysis at 405 nm.  The control consisted of 157 amino 
acid residues encoded by the pET102 plasmid.  Error bars represent standard deviations of 
the mean.  A Student’s T test was performed to compare binding of Basigin transmembrane 
segments to TLR4 in mouse heart to that of the control protein.  * indicates a p-value of less 
than 0.05. 
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Figure 3.7.  Binding affinity assays for BasTM segment binding to TLR4.   Endogenous TLR4 
was captured and incubated with recombinant Basigin transmembrane domain segments 
(BasTM 1-6 [A], BasTM 7-18 [B], BasTM 7-12 [C], BasTM 13-18 [D], BasTM 19-24[E]) at 
0.5, 1.0, 1.5, 2.5, and 5.0 M. Binding between endogenous TLR4 and the recombinant 
Basigin protein was measured using an alkaline phosphatase detection system and 
spectrophotometric assay at 405 nm. Percent binding was calculated for each 
concentration and the binding affinity of the recombinant Basigin protein for TLR4 was 
determined from the slope equation.  All runs were performed in triplicate.  Error bars 
represent standard deviations of the mean. 
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affinity = 0.109 M (Figure 3.7 D); BasTM 13-18 6XHis binding affinity = 0.160 M (Figure 
3.7 E).  Binding affinities of all recombinant Basigin transmembrane segments for TLR4 
were compared to the normal Basigin transmembrane domain containing all 24 amino acid 
residues using standard deviation and the Student’s T Test (Table 3.1).   
Based on the binding affinity comparison of each Basigin transmembrane segment, 
Basigin transmembrane residues 1-6 (BasTM 1-6 6XHis), 7-12 (BasTM 7-12 6XHis), and 
13-18 (BasTM 13-18 6XHis) have the highest affinity for TLR4 and binding affinities of 
these segments are significantly greater than the binding affinity of Basigin 
transmembrane residues 19-24 (BasTM 19-24 6XHis).  For each of these Basigin 
transmembrane segments, individual consecutive amino acids within the segment were 
mutated to glycine (G) via site-directed mutagenesis and recombinant proteins were 
generated for each of the amino acids that were mutated within that Basigin 
transmembrane segment.  All of the recombinant proteins subsequently generated 
containing these mutations were used in ELISA analyses to determine which specific amino 
acids within those segments are important for the interaction with TLR4.  All mutated 
recombinant proteins were compared to the appropriate normal recombinant Basigin 
protein segment (Figures 3.8, 3.9, and 3.10).  BasTM 1-6 was compared to recombinant 
proteins containing mutations for each consecutive amino acid within that segment (Finch 
et al., 2009; Figure 3.8).  The methionine at position 1, alanine at position 2, and alanine at 
position 3 within the Basigin 1-6 transmembrane segment appear to be essential for the 
interaction with TLR4 (BasTM 1-6 M1G p-value = 0.03; BasTM 1-6 A2G p-value = 0.01; 
BasTM 1-6 A3G p-value = 0.02).  The leucine at position 4, tryptophan at position 5, and  
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Table 3.1.  Comparison of Basigin transmembrane segment binding affinities for TLR4.  
Statistical analyses were performed to compare the binding affinities of BasTM and BasTM 
segments for TLR4 using three distinct mouse hearts. Average values were calculated for 
each protein construct and the percent binding was determined. The concentration at 
which the percent binding of the recombinant Basigin protein was 50% was calculated. 
The calculated binding affinities of each recombinant protein were compared using a 
Student’s T-test to obtain a p-value. The standard deviation was calculated for binding 
affinities from each mouse heart. 
 
Construct Affinity p-value 
BasTM 6XHis 0.742 μM ± 0.162 
 
BasTM E13G 6XHis 0.930 μM ± 0.044 0.103 
BasTM 1-6 6XHis 0.097 μM ± 0.011 0.012 
BasTM 19-24 6XHis 2.289 μM ± 0.200 0.002 
BasTM 7-12 6XHis 0.109 μM ± 0.006 0.011 
BasTM 13-18 6XHis 0.160 μM ± 0.012 0.013 
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Figure 3.8. ELISA analysis comparing BasTM 1-6 binding to TLR4 to that of recombinant 
proteins containing consecutive amino acid substitutions to glycine (G) within the BasTM 
1-6 segment.  An antibody specific for the TLR4 protein was plated followed by an 
application of mouse heart lysate.  The appropriate recombinant Basigin proteins were 
applied (BasTM 1-6 M1G 6XHis, BasTM 1-6 A2G 6XHis, BasTM 1-6 A3G 6XHis, BasTM 1-6 
L4G 6XHis, BasTM 1-6 W5G 6XHis, and BasTM 1-6 P6G 6XHis) and a primary antibody 
specific for the six histidine tag was applied.  An alkaline phosphatase-conjugated goat anti-
mouse (AP-GAM) antibody was subsequently applied.  Binding was measured using an 
alkaline phosphatase detection system and subsequent spectrophotometric analysis at 405 
nm.  Error bars represent standard deviations of the mean.  A Student’s T test was 
performed to compare binding of Basigin transmembrane segments to TLR4 in mouse 
heart to the control protein.  * indicates a p-value of less than 0.05. 
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proline at position 6 within the Basigin 1-6 transmembrane segment do not appear to be 
essential for the interaction with TLR4 because when mutated, they did not show a 
significant difference in the ability of BasTM 1-6 to bind to TLR4 than the normal Basigin 1-
6 transmembrane segment (BasTM 1-6 L4G p-value = 0.42; BasTM1-6 W5G p-value = 0.18; 
BasTM 1-6 P6G p-value = 0.11).   
The BasTM 7-12 recombinant protein was compared to recombinant proteins 
containing mutations for each consecutive amino acid within that segment (Figure 3.9).  
The phenylalanine residue at position 7, the leucine residue at position 8, and the valine 
residue at position 11 appear to be important for the interaction with TLR4 (BasTM 7-12 
F7G 6XHis p-value = 0.019; BasTM 7-12 L8G 6XHis p-value = 0.033; BasTM 7-12 V11G 
6XHis p-value = 0.025).  The isoleucine residue at position 10 and alanine residue at 
position 12 within the Basigin 7-12 transmembrane segment do not appear to be essential 
for the interaction between Basigin and TLR4 because when mutated, there was no 
significant difference in the ability of BasTM 7-12 to bind to TLR4 than the normal Basigin 
7-12 transmembrane segment (BasTM 7-12 I10G 6XHis p-value = 0.37; BasTM 7-12 A12G 
6XHis p-value = 0.28). 
The BasTM 13-18 recombinant protein was compared to recombinant proteins 
containing mutations for each consecutive amino acid within that transmembrane segment 
(Figure 3.10).  The glutamate residue at position 13, valine residues at position 14 and 16, 
and leucine residues at position 15 and 17 are important for the interaction with TLR4 
(BasTM 13-18 E13G 6XHis p-value = 0.001; BasTM 13-18 V14G 6XHis p-value = 0.017; 
BasTM 13-18 L15G 6XHis p-value = 0.007; BasTM 13-18 V16G 6XHis p-value = 0.001; 
BasTM 13-18 L17G p-value = 0.0007).  Residue 18 within the Basigin transmembrane  
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Figure 3.9. ELISA analysis comparing BasTM 7-12 binding to TLR4 to that of recombinant 
proteins containing consecutive amino acid substitutions to glycine (G) within the BasTM 
7-12 segment.  An antibody specific for the TLR4 protein was plated followed by an 
application of mouse heart lysate.  The appropriate recombinant Basigin proteins were 
applied (BasTM 7-12 F7G 6XHis, BasTM 7-12 L8G 6XHis, BasTM 7-12 I10G 6XHis, BasTM 7-
12 V11G 6XHis, BasTM 7-12 A12G 6XHis, and BasTM 7-12 6XHis) and a primary antibody 
specific for the six histidine tag was applied.  An alkaline phosphatase-conjugated goat anti-
mouse (AP-GAM) antibody was subsequently applied.  Binding was measured using an 
alkaline phosphatase detection system and subsequent spectrophotometric analysis at 405 
nm.  Error bars represent standard deviations of the mean.  A Student’s T test was 
performed to compare binding of Basigin transmembrane segments to TLR4 in mouse 
heart to the control protein.  * indicates a p-value of less than 0.05. 
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Figure 3.10. ELISA analysis comparing BasTM 13-18 binding to TLR4 to that of 
recombinant proteins containing consecutive amino acid substitutions to glycine (G) within 
the BasTM 13-18 segment.  An antibody specific for the TLR4 protein was plated followed 
by an application of mouse heart lysate.  The appropriate recombinant Basigin proteins 
were applied (BasTM 13-18 E13G 6XHis, BasTM 1318 V14G 6XHis, BasTM 13-18 L15G 
6XHis, BasTM 13-18 V16G 6XHis, BasTM 13-18 L17G 6XHis, and BasTM 13-18 V18G 6XHis) 
and a primary antibody specific for the six histidine tag was applied.  An alkaline 
phosphatase-conjugated goat anti-mouse (AP-GAM) antibody was subsequently applied.  
Binding was measured using an alkaline phosphatase detection system and subsequent 
spectrophotometric analysis at 405 nm.  Error bars represent standard deviations of the 
mean.  A Student’s T test was performed to compare binding of Basigin transmembrane 
segments to TLR4 in mouse heart to the control protein.  * indicates a p-value of less than 
0.05. 
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segment 13-18 does not appear to be essential for the interaction between Basigin and 
TLR4 because when mutated, there was no significant difference in the ability of BasTM 
13-18 to bind to TLR4 than the normal Basigin 13-18 transmembrane segment (BasTM 13-
18 V18G 6XHis p-value = 0.46). 
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Chapter 4 - Discussion 
 It has been demonstrated that Basigin has the ability to influence signaling through 
both the MyD88 and TRIF pathways, both of which are utilized by TLR4 to induce pro-
inflammatory signaling in response to LPS detection (Jeong et al., 2014).  However, the 
short Basigin cytoplasmic domain does not possess putative binding sites for MyD88 or 
TRIF (J. Brown, personal observation).  In addition, in analyzing the Basigin 
transmembrane domain sequence, it is questionable as to why a hydrophilic glutamate 
residue would be located in the hydrophobic environment of the plasma membrane.  It has 
been hypothesized that Basigin interacts with TLR4, using the charged glutamate residue 
within the transmembrane domain, to initiate MyD88 and TRIF signaling cascades via the 
TLR4 protein.  Therefore, the purpose of the present study was to determine if the Basigin 
transmembrane domain interacts with TLR4, and if so to analyze which amino acid 
residues are important for stabilizing the interaction.   
 ELISA binding analyses indicate that Basigin does interact with TLR4 via the 
transmembrane domain.  These analyses also indicate that when the glutamate residue in 
the Basigin transmembrane domain is mutated, a slight decrease in binding is observed 
although that decrease is not considered significantly different from binding of the normal 
Basigin transmembrane domain.    
 Additional assays were performed to understand what amino acid residues in the 
Basigin transmembrane domain are important for the interaction with TLR4.  Initially, the 
Basigin transmembrane domain was separated into segments consisting of six amino acid 
residues each to determine what segments have a higher affinity for the TLR4 protein.  
Site-directed mutagenesis was performed on the segments that had a high affinity for TLR4 
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such that each consecutive amino acid residue within that segment was mutated to glycine.  
These mutated transmembrane domains were then expressed as recombinant proteins 
and utilized in ELISA analyses to determine which residues within the segments are 
important for interacting with TLR4.  The binding affinity of the Basigin transmembrane 
domain for TLR4 is similar to affinities of antibody-antigen interactions in the human 
immune system (Parham, 2015).   BasTM 1-6, BasTM 7-12, and BasTM 13-18 had the 
highest affinity for TLR4, while BasTM 19-24 had a significantly lower affinity.  The 
transmembrane segments with a high affinity for TLR4 were investigated further to 
determine what residues were important for stabilizing the interaction between Basigin 
and TLR4.  
 Within the BasTM 1-6 segment, the methionine residue at position 1, and the 
alanine residues at positions 2 and 3 all appear to be essential for interacting with TLR4.  
Amino acid mutations to residues 4 through 6 did not significantly change the affinity of 
the BasTM 1-6 segment for TLR4 and did not appear to be as important as residues 1-3 in 
the Basigin 1-6 transmembrane segment.   
 Within the BasTM 7-12 segment, the phenylalanine residue at position 7, the 
leucine residue at position 8, and the valine residue at position 11 appear to be important 
for the interaction with TLR4 because mutating these residues significantly decreased 
binding between Basigin and TLR4.  The isoleucine residue at position 10 and alanine 
residue at position 12 within the Basigin transmembrane segment 7-12 do not appear to 
be essential for the interaction between Basigin and TLR4 
 Within the BasTM 13-18 segment, all of the residues including the glutamate at 
position 13, the valine residues at positions 14 and 16, and the leucine residues at 
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positions 15 and 17 appear to be important for the interaction with TLR4 because 
mutating these residues resulted in a significant decrease in binding between Basigin and 
TLR4.  The valine at position 18 does not appear to be important for the interaction 
between Basigin and TLR4.   
Although the ELISA analysis conducted using only the normal Basigin 
transmembrane domain and the transmembrane domain in which only the glutamate was 
mutated showed that the glutamate was not important for stabilizing the interaction, that 
data did show a slight decrease in binding even though it was not considered significantly 
different.  It appears that the glutamate residue is important for stabilizing the interaction 
with TLR4, along with almost all of the additional hydrophobic residues within the 13-18 
transmembrane segment.  It would be expected that if several residues are key for 
stabilizing an interaction, then a single mutation to one of those residues would not result 
in a large decrease in binding between the two proteins because the additional residues 
that were not mutated are still contributing to stabilization.  When the smaller segment 
consisting of only amino acids 13-18 was used, a significant difference in binding was 
observed, likely because the affinity of that region for TLR4 is much greater than that of the 
entire transmembrane domain, and a single amino acid change was enough to destabilize 
the interaction.   
The data indicate that mutations throughout the Basigin transmembrane domain 
produced pronounced decreases in binding to TLR4 and suggests that the Basigin-TLR4 
interaction is stabilized by both hydrophilic and hydrophobic interactions.  The 
transmembrane domain sequence of TLR4 contains hydrophobic amino acids, as well as 
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two histidine residues (accession number NM_021297.3), which have the ability to interact 
with and stabilize the glutamate residue within the Basigin transmembrane domain. 
Unlike the Basigin-TLR4 interaction characterized in this study, Finch et al., 2009 
showed that the glutamate residue in the Basigin transmembrane domain was not 
important for establishing an interaction with monocarboxylate transporter 1 (MCT1), and 
that the Basigin-MCT1 interaction was stabilized solely by hydrophobic interactions.  The 
data from the present study indicate that Basigin does utilize the transmembrane domain 
glutamate residue to stabilize the interaction with TLR4, in addition to hydrophobic 
residues.  The same study by Finch et al. demonstrated that mutations within the Basigin 
transmembrane region 19-24 produced dramatic decreases in binding between Basigin 
and MCT1, while mutations within the Basigin transmembrane segment 1-6 produced less 
dramatic decreases in binding to MCT1 (Finch et al., 2009).  The data presented in this 
study suggests that mutations within the Basigin transmembrane segment 1-6 produce 
significant decreases in binding between Basigin and TLR4.  In contrast to Finch et al., 
2009, the Basigin transmembrane segment 19-24 has a significantly lower affinity for 
TLR4 compared to transmembrane segments 1-6, 7-12, and 13-18.  Mutations within the 
Basigin transmembrane segments 7-12 and 13-18 produced significant decreases in 
binding between Basigin and TLR4, however, Finch et al., 2009 indicated that those same 
transmembrane segments were not utilized in the interaction between Basigin and MCT1.  
 It is possible that the extracellular and cytoplasmic domains of Basigin, in addition 
to the transmembrane domain, play a role in influencing signaling through the TLR4-
induced signaling pathways MyD88 and TRIF; however, the main purpose of the present 
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study was to specifically investigate the role of the Basigin transmembrane domain in pro-
inflammatory signaling pathways associated with TLR4.    
 The ability of Basigin to influence the MyD88 and TRIF signaling pathways could be 
in response to ligand binding via the extracellular domain of the Basigin protein.  Jeong et 
al. demonstrated that when an antibody specific for the Basigin protein was applied to cell 
cultures, signaling through both the MyD88 and TRIF pathways was significantly 
decreased.  It was specifically shown that the cultures in which the antibody was applied 
had lower levels of the transcription factor NF-kappaB when compared to cultures in 
which no antibody was applied (Jeong et al., 2014).  It is well established that the TLR4 
protein, in addition to the proteins MD2 and CD14, are responsible for the detection of LPS 
via the formation of a complex with the extracellular domain of TLR4 (Owen et al., 2013).  
It is not known if Basigin has the ability to interact with LPS or the proteins involved in 
forming a complex with the extracellular or cytoplasmic domains of TLR4 during the 
initiation of pro-inflammatory signaling pathways involving MyD88 and TRIF.  Because 
Basigin possesses a short cytoplasmic domain with no known putative binding sites for 
MyD88 and TRIF, yet has been documented to elicit signal transduction events through 
these pathways (Jeong et al., 2014), it is possible that the role of Basigin in pro-
inflammatory signaling is to establish an interaction with TLR4 in response to binding of 
yet to be identified ligand to carry out the signaling events.  This is reminiscent of the 
structure and activation process for the T cell receptor, which uses different proteins 
within the receptor complex to bind ligand and to elicit signal transduction (Birnbaum et 
al., 2014).   
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 It is known that Basigin is involved in the Wnt/beta-catenin pathway, a pathway 
extensively involved in embryonic development that regulates cell proliferation and 
migration (Wei et al., 2010; Logan and Nusse, 2004).  The Wnt/beta-catenin pathway is 
also a prevalent pathway associated with cancer (Reya and Clevers, 2005).  It is well 
understood that Basigin is highly expressed on the surface of tumors and serves as a cell 
surface marker for the identification of some cancer cells (Davidson et al., 2003; Yan et al., 
2005).  Unscheduled reactivation of the Wnt/beta-catenin pathway has the ability to cause 
inflammatory diseases and it is known that both developmental signaling pathways and 
inflammatory signaling pathways are used by metastatic cancer cells for the purpose of 
proliferation and the ability to alter cell interactions (Morrisey, 2003; Srikrishna and 
Freeze, 2009; Hagemann et al., 2005).  The full role of Basigin in signaling through pro-
inflammatory pathways is unknown, but it is intriguing to speculate that Basigin is 
necessary for the overlapping of Wnt/beta-catenin and pro-inflammatory pathways 
necessary for cancer cell proliferation.  In non-cancer cells, Basigin may play a role in 
initiating inflammation through TLR4 in response to LPS or another, yet to be identified 
ligand. 
In conclusion, the results of this study indicate that the Basigin and TLR4 proteins 
interact and that this interaction via the Basigin transmembrane domain is stabilized by 
both hydrophilic and hydrophobic interactions.  The Basigin transmembrane glutamate 
residue does play a role in the interaction between Basigin and TLR4 but is not entirely 
responsible for stabilizing the interaction between Basigin and TLR4, as several other 
amino acid residues appear to be key for the interaction in addition to the glutamate 
residue.  The TLR4 transmembrane domain contains two positively charged histidine 
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residues that could be important for establishing electrostatic interactions with the Basigin 
transmembrane glutamate residue.  Basigin transmembrane residues that appear to 
stabilize the interaction between the Basigin and TLR4 are located within positions 1-18 in 
the Basigin transmembrane domain.  Residues located in the 19-24 Basigin 
transmembrane region do not appear to be as important as the other residues because the 
observed binding affinity of residues 19-24 for TLR4 was significantly less than the binding 
affinities of the other transmembrane regions of Basigin.  This phenomenon allows Basigin 
to interact with TLR4 and the transporter protein MCT1 simultaneously and hence 
perform multiple tasks within the same cell. 
 
  
 51 
References 
Armant MA, Fenton MJ. 2002. Toll-like receptors: a family of pattern recognition receptors 
in mammals. Genome Biol. 3: reviews3011.1-reviews3011.6. 
Agrawal S, Yong V.  2011.  The many faces of EMMPRIN – Roles in neuroinflammation.  
Biochimica et Biophysica Acta.  1812: 213-219. 
Birnbaum M, Berry R, Hsiao Y, Zhenjun C, Shingu-Vazquez M, Yu X, Waghray D, Fischer S, 
McCluskey J, Rossjohn J, Walz T, Garcia K.  2014.  Molecular architecture of the 
alpha:beta T cell receptor-CD3 complex.  Proc Nat Acad Sci.  111:  17576-17581. 
Davidson B, Goldberg I, Berner A, Kristensen G, Reich R.  2003.  EMMPRIN is a novel 
marker of poor outcome in serious ovarian carcinoma.  Clin Exp Metastasis 20: 161-
169. 
Eissler R, Schmaderer C, Rusai K, Kuhne L, Sollinger D, Lahmer T,  Witzke , Utz J, Heemann 
U, Baumann M.  2011.  Hypertension augments cardiac toll-like receptor 4 
expression and activity.  Hypertens Res. 34: 551-558. 
Finch N, Linser P, Ochrietor J.  2009.  Hydrophobic interactions stabilize the Basigin-MCT1 
complex.  Protein J. 28: 362-368. 
Gladden L.  2004.  Lactate metabolism: A new paradigm for the third millennium.  J Physiol.  
558: 5-30.   
Hagemann T, Wilson J, Kulbe H, Li N, Leinster D, Charles K, Klemm F, Pukrop T, Binder C, 
Balkwill F.  2005. Macrophages induce invasiveness of epithelial cancer cells via NF-
kappaB and JNK.  J Immunol 175: 1197-1205. 
Halestrap A, Price N.  1999.  The proton-linked monocarboxylate transporter (MCT) family:  
structure, function and regulation.  Biochemical J.  343: 281-299. 
 52 
Hendry C, Farley A, McLafferty E, Johnstone C.  2013.  Function of the immune system.  
Nursing Standard.  27: 35-42. 
Hori K, Katayanma N, Kachi S, Konda M, Kadomatsu K, Usukura J, Muramatsu T, Mori S, 
Miyake Y.  2000.  Retinal dysfunction in Basigin deficiency.  Invest Opthalmol Vis Sci. 
41: 3128-3133. 
Jeong J, Kim E, Cho J, Yi E, Kim K.  2014.  Basigin/CD147 promotes the activation of signal 
transduction mediated by MyD88 and TRIF.  Int J Bio-Sci Bio-Tech. 6:107-116.   
Kawasaki T, Kawai T.  2014.  Toll-like receptor signaling pathways.  Front Immunol.  5:461. 
Kumar A, Shamsuddin N.  2012.  Retinal muller glia initiate innate response to infectious 
stimuli via toll-like receptor signaling.  PLoS One. 7: e29830. 
Logan C, Nusse R.  2004.  The Wnt signaling pathway in development and disease.  Annu 
Rev Cell Dev Biol. 20: 781-810. 
Lu Y, Yeh W, Ohashi P.  2008.  LPS/TLR4 signal transduction pathway.  Cytokine. 42: 145-
151. 
Morrisey E.  2003.  Wnt signaling and pulmonary fibrosis.  Am J Pathol.  162: 1393-1397. 
Nabeshima K, Iwasaki H, Koga K, Hojo H, Suzumiya J, Kikuchi M, 2006.  Emmprin 
(Basigin/CD147): Matrix metalloproteinase modulator and multifunctional cell 
recognition molecule that plays a critical role in cancer progression.  Pathol Int. 56: 
359-367. 
Naruhashi K, Kadomatsu K, Igakura T, Fan Q, Kuno N, Muramatsu H, Miyauchi T, Hasegawa 
T, Itoh A, Muramatsu T, Nabeshima T.  1997.  Abnormalities of sensory and memory 
functions in mice lacking Basigin gene.  Biochem Biophys Res Comm.  236: 733-737. 
 53 
Ochrietor JD, Moroz TM, Kadomatsu T, Linser P.  2001.  Retinal degeneration following 
failed photoreceptor maturation in 5A11/Basigin null mice.  Exp Eye Res. 72: 467-
477. 
Ochrietor JD, Moroz TP, Clamp MF, Timmers AM, Muramatsu, T, Linser PJ. 2002. 
Inactivation of the Basigin gene impairs normal retinal development and 
maturation. Vis Res. 42: 447-453. 
Ochrietor JD, Moroz TP, Ekeris L, Clamp MF, Jefferson S, deCarvalbo A, Fadool JM, Wistow 
G, Muramatsu T, Linser PJ.  2003.  Retina-specific expression of 5A11/Basigin-2, a 
member of the immunoglobulin gene superfamily. Invest Ophthalmol Vis Sci. 44: 
4086-4096. 
Ochrietor JD, Anderson E, McCormack A. 2008. Basigin gene products interact with each 
other in the vertebrate retina. Invest Ophthalmol Vis Sci. 49, E-Abstract 5894. 
Owen J, Punt J, Strandford S, Jones P.  2013.  Kuby immunology.  Seventh edition.  New 
York:  W.H. Freeman and company.  692 p.   
Parham P.  2015.  The immune system.  Fourth edition.  New York: Garland Science, Taylor 
and Francis Group.  532 p. 
Philp N, Ochrietor J, Rudoy C, Muramatsu T, Linser P.  2003.  Loss of MCT1, MCT3, and 
MCT4 expression in the retinal pigment epithelium and neural retina of the 
5A11/Basigin null mouse.  Invest Ophthalmol Vis Sci. 44: 1305-1311. 
Pollerberg G, Thelen K, Theiss M, Hochlehnert B.  2013.  The role of cell adhesion molecules 
for navigating axons: Density matters.  Mech Dev. 130: 359-372. 
Reya T, Clevers H.  2005.  Wnt signaling in stem cells and cancer.  Nature. 434: 843-850. 
 54 
Sidhu S, Nawroth R, Retz M, Lemjabbar-Alaoui H, Dasari V, Basbaum C.  2010.  EMMPRIN 
regulates the canonical Wnt/beta-catenin signaling pathway, a potential role in 
accelerating lung tumorigenesis.  Oncogene. 29 4145-4156. 
Singh P, Kumar A.  2015.  Retinal photoreceptor expresses Toll-like Receptors (TLRs) and 
elicits innate responses following TLR ligand and bacterial challenge.  PLoS One 10: 
e0119541. 
Sonderegger P.  1998.  Ig superfamily molecules in the nervous system.  Overseas 
Publishers Association (OPA).  Amsterdam, The Netherlands. 
Srikrishna G, Freeze H.  2009.  Endogenous damage associated molecular pattern 
molecules at the crossroads of inflammation and cancer.  Neoplasia. 11:  615-628. 
Vaure C, Liu Y.  2014.  A comparative review of toll-like receptor 4 expression and 
functionality in different animal species.  Front Immunol.  5: 00316.   
Wei Y, Heng G, Ben H.  2010.  Pro-inflammatory activities induced by CyPA-EMMPRIN 
interaction in monocytes.  Atherosclerosis. 213: 415-421. 
Wiersinga W, Leopold S, Cranendonk D, van der Poll T.  2014.  Host innate immune 
responses to sepsis.  Virulence.  5: 36-44. 
Yan L, Zucker S, Toole B.  2005.  Roles of the multifunctional glycoprotein emmprin 
(Basigin; CD147) in tumor progression.  Thromb Haemost. 93: 199-204. 
Zanoni I, Ostuni R, Marek LR, Barresi S, Barbalat R, Barton GM.  2011.  CD14 controls the 
LPS-induced endocytosis of toll-like receptor 4. Cell. 147: 868–80.  
 
 
 
 
 55 
Vita 
 
Name of author: Josephine M. Brown 
 
Date and place of birth: June 9, 1989 Jacksonville, Florida 
 
Degrees awarded: B.S. Biology, University of North Florida, 2014 
 
Honors and awards: UNF Biology Graduate Summer Research Grant, 2015 
 
UNF SMART Grant, 2014 
 
UNF Biology Undergraduate Summer Research Scholarship, 
2013 
 
UNF Transformational Learning (TLO) Scholarship, 2013 
 
 
Presentations: Josephine M Brown and Judith D Ochrietor 
Characterization of the interaction between Basigin and L1cam 
American Society for Cell Biology (ASCB) Conference, 2013.  
New Orleans, LA  
 
Josephine M Brown and Judith D Ochrietor 
Characterization of the interaction between Basigin and L1cam 
University of North Florida SOARS poster session, 2014. 
Jacksonville, FL 
 
Josephine M Brown and Judith D Ochrietor 
Characterization of the interaction between Basigin and the 
pattern recognition receptor TLR4 
Inflammation Conference, 2016.  Miami, FL 
 
Josephine M Brown and Judith D Ochrietor 
Characterization of the interaction between Basigin and the 
pattern recognition receptor TLR4 
University of North Florida SOARS poster session, 2016 
Jacksonville, FL 
 56 
CERTIFICATE OF APPROVAL 
 
 
The thesis “Characterization of the interaction between Basigin and the pattern recognition 
receptor TLR4” submitted by Josephine M. Brown 
 
 
Approved by the thesis committee:       Date 
 
 
_____________________________      ___________________ 
Dr. Judith Ochrietor 
Committee Chair Person 
 
 
______________________________                  ____________________ 
Dr. Terri Ellis 
 
 
______________________________                 _____________________ 
Dr. Michael Lentz 
 
 
 
Accepted for the Department: 
 
 
_______________________________               _______________________ 
Dr. Cliff Ross        
Chairperson 
 
 
Accepted for the College: 
 
 
________________________________              ________________________ 
Dr. Daniel Moon 
Dean 
 
 
Accepted for the University: 
 
 
___________________________________             _________________________ 
Dr. John Kantner 
Dean of the Graduate School 
 57 
 
